Denali Therapeutics
DNLI
#4389
Rank
C$2.43 B
Marketcap
$16.75
Share price
-7.90%
Change (1 day)
-34.78%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2023 (TTM): -$1.47

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.49. In 2022 the company made an earnings per share (EPS) of -$3.70 a decrease over its 2021 EPS that were of -$3.40.

EPS history for Denali Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.47-60.16%
2022-$3.708.79%
2021-$3.40-712.82%
2020$0.55-118.93%
2019-$2.93402.44%
2018-$0.58-88.89%
2017-$5.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.64 77.14% Jersey
-$10.22 584.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.93 96.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.82 490.48%๐Ÿ‡ฌ๐Ÿ‡ง UK